Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2600116006) titled 'The effect of tegileridine fumarate on pain scores in patients undergoing laparoscopic total hysterectomy for postoperative pain management' on Jan. 4.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of Soochow University
Condition:
Postoperation pain
Intervention:
Tegileridine group:Tegileridine fumarate loading dose: 1 mg (5 ml)
5 mg is diluted with 0.9% normal saline to 100 ml. PCIA self-administration dose: 1 ml, lockout time: 10 minutes.
Sufentanil group:Sufentanil loading dose: 10 µg (5 ml)
Recruitment Status: Not Recruiting
Phase: 4
Da...